Shares of Novavax Inc. NVAX, -2.74% slid 2.74% to $7.11 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index COMP, -1.57% falling 1.57% to 13,063.61 and Dow Jones Industrial Average DJIA, -1.14% falling 1.14% to 33,618.88.
The stock’s fall snapped a two-day winning streak.
Novavax Inc. closed $18.55 below its 52-week high ($25.66), which the company reached on November 15th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson JNJ, -0.77% fell 0.77% to $159.02, Pfizer Inc. PFE, -1.76% fell 1.76% to $32.40, and Merck & Co. Inc. MRK, -0.43% fell 0.43% to $105.39.
Trading volume (7.2 M) remained 2.5 million below its 50-day average volume of 9.7 M.